I’ve been working on this cancer for over three decades. It’s a beast! This new molecule, daraxonrasib, and others that are more specific to the mutant form of KRas are going to be game changers in not only the treatment of PDAC but also other tumors where KRas plays an important role …
Revolution Medicines shared Phase III clinical trial results for a pill called daraxonrasib in patients with previously treated metastatic pancreatic cancer.
